Adverse events in IBD: to stop or continue immune suppressant and biologic treatment
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adverse events in IBD: to stop or continue immune suppressant and biologic treatment
Authors
Keywords
-
Journal
Expert Review of Gastroenterology & Hepatology
Volume 8, Issue 3, Pages 223-240
Publisher
Informa UK Limited
Online
2014-02-04
DOI
10.1586/17474124.2014.881715
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy
- (2015) C. O. Musumba ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- 622 Risk of Subsequent Cancer Under Immunosuppressive Therapy in Patients With Inflammatory Bowel Disease and Prior Cancer: Data From the CESAME Prospective Observational Cohort
- (2015) Laurent Beaugerie et al. GASTROENTEROLOGY
- Meta-analysis: peri-operative anti-TNFα treatment and post-operative complications in patients with inflammatory bowel disease
- (2013) N. Narula et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis
- (2013) N. A. Kennedy et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Neurological events with tumour necrosis factor alpha inhibitors reported to the Food and Drug Administration Adverse Event Reporting System
- (2013) P. Deepak et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Anti-Tumor Necrosis Factor Therapy Is Associated With Infections after Abdominal Surgery in Crohn's Disease Patients
- (2013) Ali Syed et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials
- (2013) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Demyelination and other neurological adverse events after anti-TNF therapy
- (2013) Evripidis Kaltsonoudis et al. AUTOIMMUNITY REVIEWS
- Sustained Clinical Benefit and Tolerability of Methotrexate Monotherapy After Thiopurine Therapy in Patients With Crohn's Disease
- (2013) Margien L. Seinen et al. Clinical Gastroenterology and Hepatology
- Risk of Lymphoma in Patients With Ulcerative Colitis Treated With Thiopurines: A Nationwide Retrospective Cohort Study
- (2013) Nabeel Khan et al. GASTROENTEROLOGY
- Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Efficacy and Safety of Natalizumab in Crohn’s Disease Patients Treated at 6 Boston Academic Hospitals
- (2013) Pascal Juillerat et al. INFLAMMATORY BOWEL DISEASES
- Natalizumab in Crohn’s Disease
- (2013) Atsushi Sakuraba et al. INFLAMMATORY BOWEL DISEASES
- Tumor Necrosis Factor α Antagonist–associated Psoriasis in Inflammatory Diseases
- (2013) Kevin E. Kip et al. INFLAMMATORY BOWEL DISEASES
- Pneumocystis Jiroveci Pneumonia in Inflammatory Bowel Disease
- (2013) Philip N. Okafor et al. INFLAMMATORY BOWEL DISEASES
- Safety of Thiopurine Therapy in Inflammatory Bowel Disease
- (2013) María Chaparro et al. INFLAMMATORY BOWEL DISEASES
- Association Between the Initiation of Anti–Tumor Necrosis Factor Therapy and the Risk of Herpes Zoster
- (2013) Kevin L. Winthrop et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel
- (2013) Valerie Pittet et al. Journal of Crohns & Colitis
- EFFICACY AND SAFETY OF NATALIZUMAB TREATMENT FOR RELAPSING–REMITTING MULTIPLE SCLEROSIS: INTERIM RESULTS OF THE TYSABRI®OBSERVATIONAL PROGRAMME IN THE UK
- (2013) Jerome Hanna et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients
- (2013) Stefanie Dahlhaus et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Biomarkers for methotrexate-induced liver injury: Urinary protein profiling of psoriasis patients
- (2013) Rachel P.L. van Swelm et al. TOXICOLOGY LETTERS
- Natalizumab-associated complication? First case of peripheral T cell lymphoma
- (2012) Jeffrey Schowinsky et al. ACTA NEUROPATHOLOGICA
- Split-dose administration of thiopurine drugs: a novel and effective strategy for managing preferential 6-MMP metabolism
- (2012) D. Q. Shih et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry
- (2012) Gary R Lichtenstein et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Teratogen update: Methotrexate
- (2012) Sara C. Hyoun et al. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
- Gene Polymorphisms Involved in Manifestation of Leucopenia, Digestive Intolerance, and Pancreatitis in Azathioprine-Treated Patients
- (2012) Katerina Wroblova et al. DIGESTIVE DISEASES AND SCIENCES
- Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease
- (2012) Millie D. Long et al. GASTROENTEROLOGY
- Risk of Malignancies in Patients With Rheumatoid Arthritis Treated With Biologic Therapy
- (2012) Maria A. Lopez-Olivo et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Listeria infection in patients on anti-TNF treatment: Report of two cases and review of the literature
- (2012) Cândida Abreu et al. Journal of Crohns & Colitis
- A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease
- (2012) Makoto Naganuma et al. JOURNAL OF GASTROENTEROLOGY
- Lupus-Like Syndrome Attributable to Anti—Tumor Necrosis Factor α Therapy in 14 Patients During an 8-Year Period at Mayo Clinic
- (2012) David A. Wetter et al. MAYO CLINIC PROCEEDINGS
- Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab
- (2012) Per Soelberg Sørensen et al. Multiple Sclerosis Journal
- Review article: remission rates achievable by current therapies for inflammatory bowel disease
- (2011) L. Peyrin-Biroulet et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Role of Thiopurine and Anti-TNF Therapy in Lymphoma in Inflammatory Bowel Disease
- (2011) Lisa J Herrinton et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis
- (2011) X. Mariette et al. ANNALS OF THE RHEUMATIC DISEASES
- British Association of Dermatologists’ guidelines for the safe and effective prescribing of azathioprine 2011
- (2011) S.J. Meggitt et al. BRITISH JOURNAL OF DERMATOLOGY
- Methotrexate: A Drug of the Future in Ulcerative Colitis?
- (2011) Franck Carbonnel CURRENT DRUG TARGETS
- The use of methotrexate for treatment of inflammatory bowel disease in clinical practice
- (2011) Simone Saibeni et al. DIGESTIVE AND LIVER DISEASE
- Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease
- (2011) Laurent Peyrin–Biroulet et al. GASTROENTEROLOGY
- Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
- (2011) Edouard Louis et al. GASTROENTEROLOGY
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2011) William J. Sandborn et al. GASTROENTEROLOGY
- Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
- (2011) Natalie A. Molodecky et al. GASTROENTEROLOGY
- Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: Experience from a consecutive cohort of inflammatory bowel disease patients
- (2011) Daniel C. Baumgart et al. INFLAMMATORY BOWEL DISEASES
- Thiopurine treatment in inflammatory bowel disease: Response predictors, safety, and withdrawal in follow-up
- (2011) Giuseppe Costantino et al. Journal of Crohns & Colitis
- Paternal Exposure to Methotrexate and Pregnancy Outcomes
- (2011) D. BEGHIN et al. JOURNAL OF RHEUMATOLOGY
- The cutaneous and systemic manifestations of azathioprine hypersensitivity syndrome
- (2011) Jeffrey J. Bidinger et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Nodular regenerative hyperplasia: Evolving concepts on underdiagnosed cause of portal hypertension
- (2011) Marek Hartleb WORLD JOURNAL OF GASTROENTEROLOGY
- Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease
- (2011) Chadwick Williams et al. Therapeutic Advances in Gastroenterology
- Changes in Liver Biochemistry During Methotrexate Use for Inflammatory Bowel Disease
- (2010) Marc R Fournier et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A Practical Guide to Vaccinating the Inflammatory Bowel Disease Patient
- (2010) Sharmeel K Wasan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry
- (2010) D. Salmon-Ceron et al. ANNALS OF THE RHEUMATIC DISEASES
- Drug-induced lupus: An update
- (2010) Uriel Katz et al. AUTOIMMUNITY REVIEWS
- Severe Skin Lesions Cause Patients With Inflammatory Bowel Disease to Discontinue Anti–Tumor Necrosis Factor Therapy
- (2010) Jean–François Rahier et al. Clinical Gastroenterology and Hepatology
- A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease
- (2010) David S. Kotlyar et al. Clinical Gastroenterology and Hepatology
- Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy
- (2010) C. Loras et al. GUT
- Lost in translation
- (2010) Corey A. Siegel INFLAMMATORY BOWEL DISEASES
- Viral hepatitis and inflammatory bowel disease
- (2010) Jason K. Hou et al. INFLAMMATORY BOWEL DISEASES
- Nonmelanoma skin cancer in inflammatory bowel disease
- (2010) Millie D. Long et al. INFLAMMATORY BOWEL DISEASES
- Formation of antinuclear and double-strand DNA antibodies and frequency of lupus-like syndrome in anti-TNF-α antibody-treated patients with inflammatory bowel disease
- (2010) Florian Beigel et al. INFLAMMATORY BOWEL DISEASES
- Incidence of nodular regenerative hyperplasia in inflammatory bowel disease patients treated with azathioprine
- (2010) Philippe Seksik et al. INFLAMMATORY BOWEL DISEASES
- Diagnosis of melanoma under concomitant natalizumab therapy
- (2010) Bettina M Prinz Vavricka et al. Multiple Sclerosis Journal
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical experience of methotrexate in Crohn's disease: response, safety and monitoring of treatment
- (2010) R. Parker et al. POSTGRADUATE MEDICAL JOURNAL
- Efficacy of methotrexate in Crohn’s disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine
- (2009) M. WAHED et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Comparison of Two Adalimumab Treatment Schedule Strategies for Moderate-to-Severe Crohn's Disease: Results From the CHARM Trial
- (2009) Jean-Frédéric Colombel et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Adverse Events Associated With Common Therapy Regimens for Moderate-to-Severe Crohn's Disease
- (2009) Josh Marehbian et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis
- (2009) Corey A. Siegel et al. Clinical Gastroenterology and Hepatology
- Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease
- (2009) Millie D. Long et al. Clinical Gastroenterology and Hepatology
- Pharmacogenetics of Thiopurines in Inflammatory Bowel Disease
- (2009) L. Derijks et al. CURRENT PHARMACEUTICAL DESIGN
- Predictive Factors of Eczema-Like Eruptions among Patients without Cutaneous Psoriasis Receiving Infliximab: A Cohort Study of 92 Patients
- (2009) Abdolrasool Esmailzadeh et al. DERMATOLOGY
- Chronic hepatitis B: Update 2009
- (2009) Anna S. F. Lok et al. HEPATOLOGY
- General health maintenance in IBD
- (2009) Maria Moscandrew et al. INFLAMMATORY BOWEL DISEASES
- Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics
- (2009) Gil Y. Melmed INFLAMMATORY BOWEL DISEASES
- Rare Neurological Condition Linked to Newer Monoclonal Antibody Biologics
- (2009) Bridget M. Kuehn JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Methotrexate-induced pneumonitis in a patient with Crohn's disease
- (2009) Giovanna Margagnoni et al. Journal of Crohns & Colitis
- Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
- (2009) Laurent Beaugerie et al. LANCET
- Effect of Perioperative Immunosuppressive Medication on Early Outcome in Crohn’s Disease Patients
- (2009) Adrian A. Indar et al. WORLD JOURNAL OF SURGERY
- Acute pancreatitis in inflammatory bowel disease, with special reference to azathioprine-induced pancreatitis
- (2008) F. BERMEJO et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease
- (2008) A. ANSARI et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Prevalence and Factors Related to Hepatitis B and C in Inflammatory Bowel Disease Patients in Spain: A Nationwide, Multicenter Study
- (2008) Carme Loras et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Immediate Type I Hypersensitivity Response Implicated in Worsening Injection Site Reactions to Adalimumab
- (2008) Michael Paltiel et al. ARCHIVES OF DERMATOLOGY
- Allergic and Nonallergic Delayed Infusion Reactions During Natalizumab Therapy
- (2008) Kerstin Hellwig et al. ARCHIVES OF NEUROLOGY
- Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of action
- (2008) Angelique N. Collamer et al. ARTHRITIS AND RHEUMATISM
- Azathioprine Withdrawal in Patients With Crohn's Disease Maintained on Prolonged Remission: A High Risk of Relapse
- (2008) Xavier Treton et al. Clinical Gastroenterology and Hepatology
- A Randomized Trial of Methotrexate in Combination With Infliximab for the Treatment of Crohn's Disease
- (2008) Brian Feagan et al. GASTROENTEROLOGY
- Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized Trial
- (2008) Gert Van Assche et al. GASTROENTEROLOGY
- Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease
- (2008) Murat Toruner et al. GASTROENTEROLOGY
- Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study
- (2008) H Fidder et al. GUT
- Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases
- (2008) Justin M. Ko et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- EASL Clinical Practice Guidelines: Management of chronic hepatitis B
- (2008) JOURNAL OF HEPATOLOGY
- Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients
- (2008) Floor Pietersma et al. LEUKEMIA & LYMPHOMA
- Histopathology of liver biopsies from a thiopurine-naïve inflammatory bowel disease cohort: Prevalence of nodular regenerative hyperplasia
- (2008) Nanne K. H. De Boer et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started